Non-Cochrane · intervention · PM42016156
Effectiveness of arthrocentesis versus other therapeutic modalities in patients with temporomandibular disorders. Systematic review and meta-analysis.
Valenzuela-Fuenzalida Juan José, Araya-Gonzalez Florencia, Katz-Figols Ursula, et al. · The Japanese dental science review · 2026 · PubMed · doi:10.1016/j.jdsr.2026.04.001
Findings
32 findings
| Population | ||||
|---|---|---|---|---|
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Ipsilateral movement Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD -0.14 [-1.02, 0.75] GRADE not reported 2 studies · 116 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Right lateral movement Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD -1.54 [-3.64, 0.55] GRADE not reported 3 studies · 96 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Maximum mouth opening (MMO) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | SMD -0.67 [-1.14, -0.20] Low Downgraded: risk of bias, inconsistency 14 studies · 549 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Contralateral movement Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD 0.04 [-0.50, 0.58] GRADE not reported 3 studies · 153 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Mandibular movement: lateral only Oral and maxillofacial clinics · Meta-regression moderator: Proportion of women | Meta-regression coefficient (beta) -37.690 [-117.923, 42.706] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Maximum incisal opening (MIO) Oral and maxillofacial clinics · Meta-regression moderator: Proportion of women | Meta-regression coefficient (beta) -1.640 [-24.881, 21.602] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Pain intensity (VAS) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD -0.25 [-1.09, 0.59] Very low Downgraded: risk of bias, imprecision, inconsistency 26 studies · 947 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Lateral movement (only lateral) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD -0.52 [-1.13, 0.09] GRADE not reported 5 studies · 145 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Maximum incisal opening (MIO) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | SMD -2.93 [-4.54, -1.32] Very low Downgraded: risk of bias, inconsistency 11 studies · 325 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Overall mandibular movement Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD -0.40 [-0.93, 0.14] Very low Downgraded: risk of bias, imprecision, inconsistency 22 studies · 796 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Pain intensity (VAS) Oral and maxillofacial clinics · Meta-regression moderator: Proportion of women | Meta-regression coefficient (beta) -1.609 [-5.033, 1.816] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Mandibular movement: contralateral Oral and maxillofacial clinics · Meta-regression moderator: Age (years) | Meta-regression coefficient (beta) 0.074 [-0.187, 0.336] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Mandibular movement: protrusive Oral and maxillofacial clinics · Meta-regression moderator: Age (years) | Meta-regression coefficient (beta) -0.021 [-0.501, 0.460] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Mandibular movement: protrusive Oral and maxillofacial clinics · Meta-regression moderator: Proportion of women | Meta-regression coefficient (beta) -15.246 [-134.135, 103.644] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Mandibular movement: contralateral Oral and maxillofacial clinics · Meta-regression moderator: Proportion of women | Meta-regression coefficient (beta) -14.225 [-29.918, 0.469] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Left lateral movement Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD -0.42 [-3.10, 2.26] GRADE not reported 3 studies · 96 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Mandibular movement: lateral only Oral and maxillofacial clinics · Meta-regression moderator: Age (years) | Meta-regression coefficient (beta) 0.160 [0.056, 0.263] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Maximum mouth opening (MMO) Oral and maxillofacial clinics · Meta-regression moderator: Age (years) | Meta-regression coefficient (beta) -0.067 [-0.156, 0.021] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Masticatory efficiency Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD 1.15 [0.22, 2.08] Very low Downgraded: risk of bias, imprecision, inconsistency 2 studies · 55 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Protrusive movement Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified | MD 0.01 [-0.99, 1.02] GRADE not reported 6 studies · 190 participants |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Maximum incisal opening (MIO) Oral and maxillofacial clinics · Meta-regression moderator: Age (years) | Meta-regression coefficient (beta) 0.302 [-0.231, 0.836] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Maximum mouth opening (MMO) Oral and maxillofacial clinics · Meta-regression moderator: Proportion of women | Meta-regression coefficient (beta) -0.681 [-3.831, 2.470] GRADE not reported Studies not reported |
| Patients with intra-articular temporomandibular disorders (all diagnoses) | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Pain intensity (VAS) Oral and maxillofacial clinics · Meta-regression moderator: Age (years) | Meta-regression coefficient (beta) -0.028 [-0.125, 0.069] GRADE not reported Studies not reported |
| Patients with TMJ disc displacement | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Maximum mouth opening (MMO) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Disc displacement | SMD -0.48 [-1.10, 0.14] GRADE not reported 7 studies · 272 participants |
| Patients with TMJ disc displacement | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Maximum incisal opening (MIO) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Disc displacement | SMD -5.07 [-7.38, -2.75] GRADE not reported 6 studies · 173 participants |
| Patients with TMJ disc displacement | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Pain intensity (VAS) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Disc displacement | MD -0.79 [-2.10, 0.51] GRADE not reported 13 studies · 488 participants |
| Patients with TMJ osteoarthritis | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Maximum incisal opening (MIO) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Osteoarthritis | SMD -1.33 [-3.42, 0.76] GRADE not reported 4 studies · 108 participants |
| Patients with TMJ osteoarthritis | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Maximum mouth opening (MMO) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Osteoarthritis | SMD -1.27 [-2.87, 0.33] GRADE not reported 4 studies · 113 participants |
| Patients with TMJ osteoarthritis | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Pain intensity (VAS) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Osteoarthritis | MD 0.39 [-0.97, 1.74] GRADE not reported 7 studies · 190 participants |
| Patients with TMJ arthralgia | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Maximum mouth opening (MMO) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Arthralgia | SMD -0.30 [-0.76, 0.17] GRADE not reported 2 studies · 104 participants |
| Patients with TMJ arthralgia | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Pain intensity (VAS) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Arthralgia | MD -0.22 [-1.53, 1.09] GRADE not reported 2 studies · 97 participants |
| Patients with other TMJ pathologies (juvenile idiopathic arthritis, condylar fracture, TMJ dysfunction syndrome, internal derangement) | TMJ arthrocentesis, alone or with adjunctive intra-articular agents | Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) | Pain intensity (VAS) Follow-up from 1 month to 5 years across trials (mean 53 weeks) · Not specified · Other pathologies | MD 0.60 [-0.27, 1.48] GRADE not reported 4 studies · 172 participants |
Included primary studies 33
Open in Studies| Study | Year | Also included by | Outcomes it informs here | Trial data |
|---|---|---|---|---|
| Karadayi 2021 Randomised controlled trial of arthrocentesis with or without PRF for internal derangement of the TMJ. PMID:33581954 | 2021 | 4 other reviews | Pain intensity (VAS); Maximum incisal opening (MIO) | not extracted yet |
| Comert Kilic 2016 A Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis plus hyaluronic acid for the treatment of temporomandibular joint… PMID:27364372 | 2016 | 3 other reviews | Protrusive movement; Maximum incisal opening (MIO); Masticatory efficiency; Overall mandibular movement; Mandibular movement: lateral only | not extracted yet |
| Isik 2022 Injectable platelet-rich fibrin as treatment for temporomandibular joint osteoarthritis: A randomized controlled clinical trial. PMID:35798596 | 2022 | 3 other reviews | Pain intensity (VAS); Mandibular movement: contralateral; Protrusive movement; Maximum mouth opening (MMO); Overall mandibular movement; Ipsilateral movement | not extracted yet |
| Abbadi 2022 Arthrocentesis, Injectable Platelet-Rich Plasma and Combination of Both Protocols of Temporomandibular Joint Disorders Management: A… PMID:36523721 | 2022 | 2 other reviews | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Bayramoglu 2023 Does intra-articular injection of tenoxicam after arthrocentesis heal outcomes of temporomandibular joint osteoarthritis? A randomized… PMID:36890529 | 2023 | 2 other reviews | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Bergstrand 2019 Long-term effectiveness of arthrocentesis with and without hyaluronic acid injection for treatment of temporomandibular joint… PMID:30814387 | 2019 | 2 other reviews | Pain intensity (VAS); Mandibular movement: contralateral; Protrusive movement; Maximum incisal opening (MIO); Overall mandibular movement; Mandibular movement: lateral only | not extracted yet |
| Dasukil 2022 Intra-articular injection of hyaluronic acid versus platelet-rich plasma following single puncture arthrocentesis for the management of… PMID:36372680 | 2022 | 2 other reviews | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Ghoneim 2021 Treatment of temporomandibular joint disc displacement using arthrocentesis combined with injectable platelet rich fibrin versus… PMID:35028072 | 2022 | 2 other reviews | Pain intensity (VAS); Maximum incisal opening (MIO); Overall mandibular movement; Right lateral movement; Left lateral movement | not extracted yet |
| Yapici-Yavuz 2018 A comparison of the effects of Methylprednisolone Acetate, Sodium Hyaluronate and Tenoxicam in the treatment of non-reducing disc… PMID:29680845 | 2018 | 2 other reviews | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Chandra 2021 Minimally invasive intraarticular platelet rich plasma injection for refractory temporomandibular joint dysfunction syndrome in comparison… PMID:34017736 | 2021 | 1 other review | Pain intensity (VAS); Maximum incisal opening (MIO) | not extracted yet |
| Olsen-Bergem 2014 A cohort study of patients with juvenile idiopathic arthritis and arthritis of the temporomandibular joint: outcome of arthrocentesis with… PMID:24794763 | 2014 | 1 other review | Pain intensity (VAS) | not extracted yet |
| Yilmaz 2019 Comparison of treatment efficacy between hyaluronic acid and arthrocentesis plus hyaluronic acid in internal derangements of… PMID:31451342 | 2019 | 1 other review | Pain intensity (VAS) | not extracted yet |
| Alpaslan 2001 Efficacy of temporomandibular joint arthrocentesis with and without injection of sodium hyaluronate in treatment of internal derangements. PMID:11381380 | 2001 | this review only | Overall mandibular movement; Mandibular movement: lateral only | not extracted yet |
| Ansar 2022 Prognostic criteria for the management of temporomandibular disorders using arthrocentesis with normal saline and arthrocentesis with… PMID:35815075 | 2022 | this review only | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Bayramoglu 2019 Comparison of single- and double-puncture arthrocentesis for the treatment of temporomandibular joint disorders: A six-month, prospective… PMID:31021311 | 2021 | this review only | Maximum mouth opening (MMO) | not extracted yet |
| Bhargava 2019 Ultrasound-guided arthrocentesis using single-puncture, double-lumen, single-barrel needle for patients with temporomandibular joint acute… PMID:30923970 | 2019 | this review only | Pain intensity (VAS) | not extracted yet |
| Comert Kilic 2016 B Does Injection of Corticosteroid After Arthrocentesis Improve Outcomes of Temporomandibular Joint Osteoarthritis? A Randomized Clinical… PMID:27376184 | 2016 | this review only | Pain intensity (VAS); Protrusive movement; Maximum incisal opening (MIO); Masticatory efficiency; Overall mandibular movement; Mandibular movement: lateral only | not extracted yet |
| Folle 2018 Double puncture versus single puncture arthrocentesis for the management of unilateral temporomandibular joint disc displacement without… PMID:30446325 | 2018 | this review only | Pain intensity (VAS) | not extracted yet |
| Fridrich 1996 Prospective comparison of arthroscopy and arthrocentesis for temporomandibular joint disorders. PMID:8676225 | 1996 | this review only | Maximum incisal opening (MIO) | not extracted yet |
| Gorrela 2017 Efficacy of Temporomandibular Joint Arthrocentesis with Sodium Hyaluronate in the Management of Temporomandibular Joint Disorders: A… PMID:29038631 | 2017 | this review only | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Goudot 2000 Improvement of pain and function after arthroscopy and arthrocentesis of the temporomandibular joint: a comparative study. PMID:10851672 | 2000 | this review only | not stated | not extracted yet |
| Grossmann 2020 Comparison of two needles arthrocentesis versus double needle cannula arthrocentesis in the treatment of temporomandibular disc… PMID:32475229 | 2022 | this review only | Pain intensity (VAS); Maximum incisal opening (MIO) | not extracted yet |
| Grossmann 2021 Comparison between TMJ arthrocentesis techniques with different needle positions: A randomized single-blind controlled clinical trial. PMID:33642116 | 2021 | this review only | Protrusive movement; Maximum incisal opening (MIO); Overall mandibular movement; Right lateral movement; Left lateral movement | not extracted yet |
| Gupta 2023 Role of Intra-articular Piroxicam in the Temporomandibular Joint After Arthrocentesis for Anterior Disc Displacement Without Reduction. PMID:36891013 | 2023 | this review only | Protrusive movement; Maximum mouth opening (MMO); Overall mandibular movement; Mandibular movement: lateral only | not extracted yet |
| Marzook 2019 Intra-articular injection of a mixture of hyaluronic acid and corticosteroid versus arthrocentesis in TMJ internal derangement. PMID:31121331 | 2020 | this review only | Pain intensity (VAS); Maximum incisal opening (MIO); Overall mandibular movement; Right lateral movement; Left lateral movement | not extracted yet |
| Nogami 2014 Clinical comparison between arthrocentesis and conventional conservative treatment with maxillomandibular fixation for unilateral high… PMID:24372314 | 2014 | this review only | Pain intensity (VAS) | not extracted yet |
| Ohrnell Malekzadeh 2019 Conservative therapy versus arthrocentesis for the treatment of symptomatic disk displacement without reduction: a prospective randomized… PMID:31027963 | 2019 | this review only | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Onder 2009 Long-term results of arthrocentesis in degenerative temporomandibular disorders. PMID:18996032 | 2009 | this review only | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Rajput 2020 A Comparative Analysis of Intra-articular Injection of Platelet-Rich Plasma and Arthrocentesis in Temporomandibular Joint Disorders. PMID:35400915 | 2022 | this review only | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
| Sivri 2016 Comparison of ultrasound-guided and conventional arthrocentesis of the temporomandibular joint. PMID:27118616 | 2016 | this review only | Pain intensity (VAS); Maximum incisal opening (MIO) | not extracted yet |
| Tang 2023 Arthrocentesis versus non-surgical intervention as initial treatment for temporomandibular joint arthralgia: a randomized controlled trial… PMID:36117007 | 2023 | this review only | Pain intensity (VAS) | not extracted yet |
| Tatli 2017 Comparison of the effectiveness of three different treatment methods for temporomandibular joint disc displacement without reduction. PMID:28222947 | 2017 | this review only | Pain intensity (VAS); Mandibular movement: contralateral; Maximum mouth opening (MMO); Overall mandibular movement; Ipsilateral movement | not extracted yet |
| Vos 2014 Arthrocentesis as initial treatment for temporomandibular joint arthropathy: a randomized controlled trial. PMID:23994055 | 2014 | this review only | Pain intensity (VAS); Maximum mouth opening (MMO) | not extracted yet |
Overlap with other reviews
Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.
Review question
| Element | Planned (methods) | Found (results) |
|---|---|---|
| Population | Patients diagnosed with intra-articular temporomandibular disorders | TMD patients: disc displacement, osteoarthritis, arthralgia, other pathologies; 1247 patients (640 arthrocentesis, 607 comparators) in 32 trials |
| Intervention | Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents | Arthrocentesis alone or with hyaluronic acid, PRP, i-PRF, corticosteroids or NSAIDs (n=32) |
| Comparison | Conservative therapies (occlusal splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols | Splints and conservative care, intra-articular injections, arthroscopy, other arthrocentesis protocols (n=32) |
| Outcomes | Pain intensity (VAS); maximum mouth opening, maximum incisal opening, mandibular movements, masticatory efficiency | VAS (n=26), MMO (n=14), MIO (n=11), masticatory efficiency (n=2), mandibular movements (n=22) |
| Study designs | Randomized controlled trials | 32 RCTs (Table 1 lists 33 trials) |
| Timing | Not specified | Follow-up 1 to 24 months; mean 53 weeks |
AMSTAR 2 items
Two independent extractors rated each item. Their ratings are shown side by side because they have not been reconciled yet. The overall rating follows Shea et al. 2017: one critical flaw gives Low, more than one gives Critically Low.
| Item | Extractor A | Extractor B | Agree |
|---|---|---|---|
| 1Research question includes PICO components | Yes | Yes | yes |
| 2Protocol established before the reviewcritical | Partial Yes | Yes | no |
| 3Choice of study designs explained | No | No | yes |
| 4Comprehensive literature searchcritical | No | Partial Yes | no |
| 5Study selection in duplicate | Yes | Yes | yes |
| 6Data extraction in duplicate | Yes | Yes | yes |
| 7List of excluded studies with reasonscritical | Yes | Yes | yes |
| 8Included studies described in detail | Yes | Yes | yes |
| 9Risk of bias assessed satisfactorilycritical | RCT: Yes · NRSI: N/A | NRSI: N/A · RCT: Yes | no |
| 10Funding of included studies reported | No | No | yes |
| 11Appropriate meta-analysis methodscritical | RCT: No · NRSI: N/A | NRSI: N/A · RCT: No | no |
| 12Impact of risk of bias on the pooled results | No | No | yes |
| 13Risk of bias accounted for in interpretationcritical | Yes | Yes | yes |
| 14Heterogeneity explained | Yes | Yes | yes |
| 15Publication bias investigatedcritical | No | No | yes |
| 16Conflicts of interest reported | Yes | Yes | yes |
| Overall | Critically Low | Critically Low | yes |